The Journal of NeuroVirology (JNV) provides a unique platform for the publication of high-quality basic science and clinical studies on the molecular biology and pathogenesis of viral infections of the nervous system, and for reporting on the development of novel therapeutic strategies using neurotropic viral vectors. The Journal also emphasizes publication of non-viral infections that affect the central nervous system. The Journal publishes original research articles, reviews, case reports, coverage of various scientific meetings, along with supplements and special issues on selected subjects.
The Journal is currently accepting submissions of original work from the following basic and clinical research areas: Aging & Neurodegeneration, Apoptosis, CNS Signal Transduction, Emerging CNS Infections, Molecular Virology, Neural-Immune Interaction, Novel Diagnostics, Novel Therapeutics, Stem Cell Biology, Transmissable Encephalopathies/Prion, Vaccine Development, Viral Genomics, Viral Neurooncology, Viral Neurochemistry, Viral Neuroimmunology, Viral Neuropharmacology.
Journal information
- Editor-in-Chief
-
- Kamel Khalili
- Publishing model
- Hybrid (Transformative Journal). Learn about publishing Open Access with us
Journal metrics
- 2.354 (2019)
- Impact factor
- 2.763 (2019)
- Five year impact factor
- 71 days
- Submission to first decision
- 128 days
- Submission to acceptance
- 130,020 (2020)
- Downloads
Latest issue
Latest articles
-
-
Untreated herpes simplex virus encephalitis without a fatal outcome
Authors (first, second and last of 7)
-
Limbic encephalitis in a COVID-19 patient?
Authors (first, second and last of 11)
-
-
Journal updates
-
Announcement: COVID-19 impact on peer review
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
Societies, partners and affiliations
About this journal
- Electronic ISSN
- 1538-2443
- Print ISSN
- 1355-0284
- Abstracted and indexed in
-
- BIOSIS
- Biological Abstracts
- CAB Abstracts
- CNKI
- Chemical Abstracts Service (CAS)
- Current Contents/ Life Sciences
- Dimensions
- EBSCO Academic Search
- EBSCO Biomedical Reference Collection
- EBSCO Discovery Service
- EBSCO STM Source
- EMBASE
- EMBiology
- Google Scholar
- Institute of Scientific and Technical Information of China
- Japanese Science and Technology Agency (JST)
- Journal Citation Reports/Science Edition
- Medline
- Meta
- Naver
- Norwegian Register for Scientific Journals and Series
- OCLC WorldCat Discovery Service
- Pathway Studio
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index Expanded (SciSearch)
- TD Net Discovery Service
- UGC-CARE List (India)
- Copyright information